会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Coated, platform-generating tablet
    • US06720005B1
    • 2004-04-13
    • US09887318
    • 2001-06-21
    • James W. Ayres
    • James W. Ayres
    • A61K936
    • A61K9/2846A61K9/2059A61K9/2072A61K9/2866
    • An expanding tablet is described comprising a drug release controlling membrane material. After swallowing, the tablet hydrates and expands such that the membrane ruptures to directly expose some surfaces of the core tablet to hydrating and eroding liquids, thus generating in situ a tablet which is platform supported on non-exposed surfaces, and which releases active ingredient in approximately zero order fashion. More particularly, the dosage form is adapted for controlled release of various pharmaceuticals. A working embodiment of the tablet was a spray-coated tablet comprising a core having greater than 25% of an expandable material which expands upon exposure to an aqueous environment and at least one active ingredient, e.g., glipizide, and an outer rupturable coating surrounding the core comprising a rate release modifying membrane and a water-soluble modifier. A method for administering an active ingredient also is described. The method comprises (1) providing a tablet according to the invention, and (2) administering the tablet to a patient.
    • 3. 发明授权
    • Process for separating radioactive and hazardous metal contaminants from
soils
    • 将放射性和有害金属污染物与土壤分离的过程
    • US4783253A
    • 1988-11-08
    • US853995
    • 1986-04-21
    • James W. AyresAlfred W. Western
    • James W. AyresAlfred W. Western
    • B07C5/346B09C1/02B07C5/34B03B5/16
    • B07C5/346B09C1/02
    • A process for treating radioactive contaminated soils to remove radioactive metal oxide contaminants therefrom comprises creating a suspension of particles of the soil in a column of water, alternately forcing fresh water in the column upwardly to force ligher soil particles upwardly in the column and allowing heavier particles to gravitationally settle in the bottom of the water column. The heavy particles comprising radioactive metal oxides are collected and handled for radioactive waste material storage. The aqueous slurry of lighter soil particles is directed to a separator for removing substantial amounts of water after which the particles are directed to a conveyor and spread out to a substantially uniform thickness and detected for any radioactivity. Portions of material in which radioactive particles are detected ar diverted and the uncontaminated soil material is recovered.
    • 用于处理放射性污染土壤以除去其中的放射性金属氧化物污染物的方法包括在水柱中产生土壤颗粒的悬浮液,交替地迫使柱中的淡水向上施力以迫使土壤颗粒在柱中向上并允许较重的颗粒 重力沉降在水柱的底部。 收集并处理包含放射性金属氧化物的重粒子用于放射性废物储存。 较轻土壤颗粒的含水浆液被引导到用于除去大量水的分离器,之后将颗粒引导到输送机上并展开至基本上均匀的厚度并且检测任何放射性。 检测到放射性粒子的部分材料被转移,未被污染的土壤物质被回收。
    • 4. 发明授权
    • Two-membrane medicated device for rate-controlled administration of
prostaglandins
    • 用于速率控制前列腺素给药的双膜药物装置
    • US4237888A
    • 1980-12-09
    • US23126
    • 1979-03-23
    • Theodore J. RosemanOsmer C. CarpenterRichard W. BakerJames W. Ayres
    • Theodore J. RosemanOsmer C. CarpenterRichard W. BakerJames W. Ayres
    • A61F13/20A61K9/00A61K31/557
    • A61F13/28A61F13/2051A61F13/2068A61F13/2074A61K31/557A61K9/0036A61F13/2011A61F2013/8414
    • The present specification describes a medicated device adapted for a single, acute, and rate-controlled rectal or vaginal administration to a mammal of a lipophilic prostaglandin. The device accomplishes drug administration at an essentially time-independent rate of dosage. Further, the device advantageously results in the substantial exhaustion of the prostaglandin from the device at the conclusion of the single, acute use. The device comprises three elements:(A) an inert resilient support means contoured for easy vaginal or rectal insertion;(B) a first flexible polymer film layer affixed to the support means and containing the prostaglandin dispersed therethrough, this first polymer film not being rate limiting as to the release of drug from the device; and(C) a second polymer film, laminated onto the first polymer film and providing a release rate therefrom of prostaglandin, which is rate limiting both as to the release of prostaglandin from the device and absorption rate by the rectal or vaginal tissues.
    • 本说明书描述适用于对亲脂性前列腺素的哺乳动物的单次,急性和速率控制的直肠或阴道给药的药物装置。 该装置以基本上时间独立的剂量速率实现药物给药。 此外,该装置有利地导致在单次急性使用结束时来自装置的前列腺素的显着耗尽。 该装置包括三个元件:(A)易于阴道或直肠插入的惰性弹性支撑装置; (B)固定在支撑装置上并含有分散在其中的前列腺素的第一柔性聚合物膜层,该第一聚合物膜不限制药物从装置中的释放; 和(C)第二聚合物膜,层压在第一聚合物膜上并提供前列腺素的释放速率,前列腺素的释放速率限于前列腺素从装置中的释放和由直肠或阴道组织吸收的速率。
    • 9. 发明申请
    • Fluid-jet pens configured for making modulated release bioactive agents
    • 配置用于制备调制释放生物活性剂的流体喷枪
    • US20090317458A1
    • 2009-12-24
    • US12551134
    • 2009-08-31
    • JOHN STEPHEN DUNFIELDJAMES W. AYRES
    • JOHN STEPHEN DUNFIELDJAMES W. AYRES
    • A61K9/127
    • A61K9/10A61K9/1075A61K9/113A61K9/1277
    • The present invention is drawn to methods of preparing a bioactive agent-containing emulsion for delivery to a biological system. This method can comprise the step of jetting a bioactive agent and a first fluid medium from a fluid-jet pen into a second fluid medium to form a bioactive agent-containing emulsion, wherein the second fluid comprises a continuous phase of the emulsion. Alternatively, a method of preparing a bioactive agent-containing liposome can comprise jetting a lipid-containing composition and a bioactive agent from a fluid-jet pen into a medium to form a bioactive agent-containing liposome carried by the medium. The present invention is also drawn to fluid-jet pens and systems configured for making liposome- and emulsion-containing biological agents.
    • 本发明涉及制备用于递送至生物系统的含生物活性剂的乳液的方法。 该方法可以包括将生物活性剂和第一流体介质从流体喷射笔喷射到第二流体介质中以形成含生物活性剂的乳液的步骤,其中第二流体包含乳液的连续相。 或者,制备含生物活性剂的脂质体的方法可以包括将来自流体喷射笔的含脂质组合物和生物活性剂喷射到培养基中以形成由培养基携带的含生物活性剂的脂质体。 本发明还涉及配置用于制备含脂质体和乳液的生物制剂的流体喷射笔和系统。
    • 10. 发明授权
    • Coated, platform-generating tablet
    • 涂层平台生产平板电脑
    • US06733784B1
    • 2004-05-11
    • US10334835
    • 2002-12-31
    • James W. Ayres
    • James W. Ayres
    • A61K928
    • A61K9/2846A61K9/2059A61K9/2072A61K9/2866
    • An expanding tablet is described comprising a drug release controlling membrane material. After swallowing, the tablet hydrates and expands such that the membrane ruptures to directly expose some surfaces of the core tablet to hydrating and eroding liquids, thus generating in situ a tablet which is platform supported on non-exposed surfaces, and which releases active ingredient in approximately zero order fashion. More particularly, the dosage form is adapted for controlled release of various pharmaceuticals. A working embodiment of the tablet was a spray-coated tablet comprising a core having greater than 25% of an expandable material which expands upon exposure to an aqueous environment and at least one active ingredient, e.g., glipizide, and an outer rupturable coating surrounding the core comprising a rate release modifying membrane and a water-soluble modifier. A method for administering an active ingredient also is described. The method comprises (1) providing a tablet according to the invention, and (2) administering the tablet to a patient.
    • 描述了包含药物释放控制膜材料的膨胀片剂。 吞咽后,片剂水合并膨胀,使得膜破裂以直接暴露芯片的一些表面以水合和侵蚀液体,从而原位产生平板支撑在非暴露表面上的片剂,并释放活性成分 大概零级时尚。 更具体地,剂型适于各种药物的控制释放。 片剂的一个实施方案是喷涂片剂,其包含具有大于25%的可膨胀材料的核心,所述可膨胀材料在暴露于水性环境中时膨胀,并且至少一种活性成分例如格列吡嗪和外部可破裂涂层 芯包含速率释放修饰膜和水溶性改性剂。 还描述了施用活性成分的方法。 该方法包括(1)提供根据本发明的片剂,和(2)将片剂给予患者。